core-biopharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Meta Tags
Title Zhimeng
Description EXCELLENCE, INTEGRITY, Zhimeng Biopharma is a startup biotech founded in 2017 by seasoned pharmaceutical industry veterans. Located in the economy-vibrant and resource-rich Zhangjiang High-Tech Park of Shanghai, China, Zhimeng is developing medicines for the treatment of
Keywords Zhimeng Biopharma,挚盟
Server Information
WebSite core-biopharma faviconcore-biopharma.com
Host IP 47.92.230.99
Location China
Related Websites
Site Rank
More to Explore
core-biopharma.com Valuation
US$680,974
Last updated: 2023-05-16 09:43:41

core-biopharma.com has Semrush global rank of 15,542,891. core-biopharma.com has an estimated worth of US$ 680,974, based on its estimated Ads revenue. core-biopharma.com receives approximately 78,574 unique visitors each day. Its web server is located in China, with IP address 47.92.230.99. According to SiteAdvisor, core-biopharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$680,974
Daily Ads Revenue US$629
Monthly Ads Revenue US$18,858
Yearly Ads Revenue US$226,293
Daily Unique Visitors 5,239
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
core-biopharma.com. A 600 IP: 47.92.230.99
core-biopharma.com. NS 21600 NS Record: dns16.hichina.com.
core-biopharma.com. NS 21600 NS Record: dns15.hichina.com.
HtmlToTextCheckTime:2023-05-16 09:43:41
Zhimeng Biopharma EN | 简体 Home About Us People Leadership Team Scientific Advisors Pipeline News Investors Join Us Contact --> EXCELLENCE, INTEGRITY, COMPASSION EXCELLENCE, INTEGRITY, COMPASSION Previous Next Our Mission Discover and develop the most effective, safe and affordable drugs to improve the quality of life of patients in China and abroad. Learn More © 2018 Copyright --> Quick Links About Us Contact Us Join Us Pipeline Leadership Team Management Team --> Scientific Advisors Recent News Zhimeng Biopharma Entered into A Global Exclusive Licensing Agreement with GlaxoSmithKline in HBV Zhimeng Biopharma Announces Dosing of First Subject in Phase II Clinical Trial of Its Novel HBV Capsid Assembly Modulator Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase I Clinical Trial of CB06 © 2023 Zhimeng Biopharma.
HTTP Headers
HTTP/1.1 200 OK
Server: nginx
Date: Sat, 22 Jan 2022 09:04:13 GMT
Content-Type: text/html; charset=utf-8
Connection: keep-alive
Vary: Accept-Encoding
X-Powered-By: PHP/5.6.34
core-biopharma.com Whois Information
Domain Name: CORE-BIOPHARMA.COM
Registry Domain ID: 2333219803_DOMAIN_COM-VRSN
Registrar WHOIS Server: grs-whois.hichina.com
Registrar URL: http://www.net.cn
Updated Date: 2018-11-16T04:47:09Z
Creation Date: 2018-11-16T04:41:17Z
Registry Expiry Date: 2024-11-16T04:41:17Z
Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd.
Registrar IANA ID: 420
Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com
Registrar Abuse Contact Phone: +86.95187
Domain Status: ok https://icann.org/epp#ok
Name Server: DNS15.HICHINA.COM
Name Server: DNS16.HICHINA.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-01-22T09:09:52Z <<<